Proactive Investors - Run By Investors For Investors

Collagen Solutions jumps as it raises £6mln at a premium, including investment from US agriculture giant

Rosen’s Diversified, America’s fifth-largest beef processor, is investing £4.2mln into Collagen as part of its plans to get into the animal tissue-related biomedical products space
knee surgery
In addition to the investment, Rosen’s will also supply tissue to Collagen

Collagen Solutions PLC (LON:COS) shares leapt higher on Monday as the firm said it is to raise £6mln at a premium to its current share price, with a multi-billion-dollar US agriculture company agreeing to pump in the majority of the cash.

Rosen’s Diversified, the fifth largest beef processor in the US and valued by Forbes at over £2.4bn (US$3bn), is to invest £4.2mln into Collagen through the purchase of 83.6mln shares at 5p apiece – almost 25% above Friday’s closing price.

READ: Collagen Solutions expects full-year revenues to beat market forecasts

A separate placing and open offer at the same price among existing investors will raise up to a further £1.8mln, and one major shareholder has already committed to taking up their entitlement of 8mln shares.

The money will allow Collagen to expand its contract manufacturing activities, develop new products, and help with the commercialisation of ChondroMimetic – its knee cartilage scaffold that is awaiting sign-off by European regulators.

It will also be used to pay off debts and fund working capital.

“We are pleased to welcome Rosen's Diversified Inc. as our strategic partner and anchor investor in this round,” said chief executive Jamal Rushdy.

“This funding round will support continued growth of our core business, including our supply of collagen and tissue biomaterials as well as new product development contracts activity, providing the company a solid foundation over the next several years.”

He added: “In addition, the funding will support our launch of ChondroMimetic following review and approval of the data we previously submitted to our Notified Body.”

Tissue supply deal agreed

Rosen’s strategic investment is part of its plans to get into the animal tissue-related biomedical products space.

AIM-quoted Collagen uses collagen and/or animal tissue, such as pericardium, to make everything from heart valves to bone grafts right through to wound dressings.

As well as investing in Collagen, Rosen’s Scientific Life Solutions subsidiary has agreed a deal which will see it supply tissue to the company.

In afternoon trading, shares in Collagen Solutions were 17.3% higher at 4.75p.

 -- Adds share price --

View full COS profile View Profile

Collagen Solutions PLC Timeline

Related Articles

human kidneys
May 06 2019
The Danish company is seeking FDA approval of the test for use in both adults and children
Callitas CEO James Thompson
July 20 2018
CannaStrips will generate near-term revenue, while the company’s blue-sky pharmaceutical assets and orphan drug are solid, long-term plays
cannabis
February 27 2019
The company is a leader for dried flower vaporizers, and a pioneer in cannabis telemedicine and AI technologies

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use